Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults

Experimental Gerontology

Volumn 48, Issue 12, 2013, Pages 1428-1435

  Mangialasche, Francesca ^a,b   Solomon, Alina ^a,c   Kåreholt, Ingemar ^a   Hooshmand, Babak ^a   Cecchetti, Roberta ^b   Fratiglioni, Laura ^a   Soininen, Hilkka ^c   Laatikainen, Tiina ^c,d   Mecocci, Patrizia ^b   Kivipelto, Miia ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Alzheimer's disease; Cognitive impairment; Oxidative nitrosative stress; Tocopherol; Tocotrienol; Vitamin E

Indexed keywords

5 NITRO GAMMA TOCOPHEROL; ALPHA TOCOPHEROL; ALPHA TOCOPHERYLQUINONE; ALPHA TOCOTRIENOL; BETA TOCOPHEROL; BETA TOCOTRIENOL; CHOLESTEROL; DELTA TOCOTRIENOL; GAMMA TOCOPHEROL; GAMMA TOCOTRIENOL; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FINNISH; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MORBIDITY; POPULATION RESEARCH; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

5-NITRO-Γ-TOCOPHEROL; 5-NO(2)-Γ-TOCOPHEROL; AD; ALZHEIMER'S DISEASE; APOE; APOLIPOPROTEIN E; BMI; BODY MASS INDEX; CAIDE; CARDIOVASCULAR RISK FACTORS, AGING, AND DEMENTIA STUDY; CDR; CENTRAL NERVOUS SYSTEM; CERAD; CI; CLINICAL DEMENTIA RATING SCALE; CNS; COEFFICIENT OF VARIATION; COGNITIVE IMPAIRMENT; CONFIDENCE INTERVAL; CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMER'S DISEASE; CV; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FOURTH EDITION; DSM-IV; HDL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH-DENSITY LIPOPROTEIN; HPLC; LDL; LOW-DENSITY LIPOPROTEIN; MAGNETIC RESONANCE IMAGING; MCI; MILD COGNITIVE IMPAIRMENT; MINI-MENTAL STATE EXAMINATION; MMSE; MRI; NATIONAL INSTITUTE OF NEUROLOGIC AND COMMUNICATIVE DISORDERS AND STROKE-ALZHEIMER'S DISEASE AND RELATED DISORDERS ASSOCIATION; NINCDS-ADRDA; NITROSATIVE STRESS; NS; ODDS RATIO; OR; OS; OXIDATIVE STRESS; OXIDATIVE/NITROSATIVE STRESS; REACTIVE NITROGEN SPECIES; RNS; SD; STANDARD DEVIATION; TOCOPHEROL; TOCOTRIENOL; VITAMIN E; Α-TOCOPHERYLQUINONE; ΑTQ;

AGE FACTORS; AGED; AGING; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; COGNITION; DISEASE PROGRESSION; FEMALE; FINLAND; HUMANS; INCIDENCE; LINEAR MODELS; LOGISTIC MODELS; MALE; MILD COGNITIVE IMPAIRMENT; ODDS RATIO; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TOCOPHEROLS; TOCOTRIENOLS; VITAMIN E;

EID: 84886038692     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2013.09.006     Document Type: Article

References (57)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC. Fourth edition.
2. Andres-Lacueva C., Shukitt-Hale B., Galli R.L., Jauregui O., Lamuela-Raventos R.M., Joseph J.A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr. Neurosci. 2005, 8:111-120.
3. Bowman G.L., Silbert L.C., Howieson D., Dodge H.H., Traber M.G., Frei B., Kaye J.A., Shannon J., Quinn J.F. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2012, 78:241-249.
4. Comstock G.W., Burke A.E., Hoffman S.C., Norkus E.P., Gross M., Helzlsouer K.J. The repeatability of serum carotenoid, retinoid, and tocopherol concentrations in specimens of blood collected 15years apart. Cancer Epidemiol. Biomarkers Prev. 2001, 10:65-68.
5. Craft N.E., Haitema T.B., Garnett K.M., Fitch K.A., Dorey C.K. Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J. Nutr. Health Aging 2004, 8:156-162.
6. Devore E.E., Grodstein F., van Rooij F.J., Hofman A., Stampfer M.J., Witteman J.C., Breteler M.M. Dietary antioxidants and long-term risk of dementia. Arch. Neurol. 2010, 67:819-825.
7. Dixon L.B., Subar A.F., Wideroff L., Thompson F.E., Kahle L.L., Potischman N. Carotenoid and tocopherol estimates from the NCI diet history questionnaire are valid compared with multiple recalls and serum biomarkers. J. Nutr. 2006, 136:3054-3061.
8. Engelhart M.J., Ruitenberg A., Meijer J., Kiliaan A., van Swieten J.C., Hofman A., Witteman J.C., Breteler M.M. Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline. Dement. Geriatr. Cogn. Disord. 2005, 19:134-139.
9. Farina N., Isaac M.G., Clark A.R., Rusted J., Tabet N. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst. Rev. 2012, 11. CD002854.
10. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
11. Food and Nutrition Board, and Institute of Medicine Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids 2000, National Academy Press, Washington, DC.
12. Ford E.S., Schleicher R.L., Mokdad A.H., Ajani U.A., Liu S. Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population. Am. J. Clin. Nutr. 2006, 84:375-383.
13. Fratiglioni L., Mangialasche F., Qiu C. Brain aging: lessons from community studies. Nutr. Rev. 2010, 68(Suppl. 2):S119-S127.
14. Galli F., Polidori M.C., Stahl W., Mecocci P., Kelly F.J. Vitamin E biotransformation in humans. Vitam. Horm. 2007, 76:263-280.
15. Helbig D., Wagner A., Schubert R., Jahreis G. Tocopherol isomer pattern in serum and stool of human following consumption of black currant seed press residue administered in whole grain bread. Clin. Nutr. 2009, 28:662-667.
16. Helmer C., Peuchant E., Letenneur L., Bourdel-Marchasson I., Larrieu S., Dartigues J.F., Dubourg L., Thomas M.J., Barberger-Gateau P. Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study. Eur. J. Clin. Nutr. 2003, 57:1555-1561.
17. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982, 140:566-572.
18. Kivipelto M., Helkala E.L., Hanninen T., Laakso M.P., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001, 56:1683-1689.
19. Knekt P., Marniemi J., Teppo L., Heliovaara M., Aromaa A. Is low selenium status a risk factor for lung cancer?. Am. J. Epidemiol. 1998, 148:975-982.
20. Krikorian R., Shidler M.D., Nash T.A., Kalt W., Vinqvist-Tymchuk M.R., Shukitt-Hale B., Joseph J.A. Blueberry supplementation improves memory in older adults. J. Agric. Food Chem. 2010, 58:3996-4000.
21. Mangialasche F., Polidori M.C., Monastero R., Ercolani S., Camarda C., Cecchetti R., Mecocci P. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res. Rev. 2009, 8:285-305.
22. Mangialasche F., Kivipelto M., Mecocci P., Rizzuto D., Palmer K., Winblad B., Fratiglioni L. High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. J. Alzheimers Dis. 2010, 20:1029-1037.
23. Mangialasche F., Xu W., Kivipelto M., Costanzi E., Ercolani S., Pigliautile M., Cecchetti R., Baglioni M., Simmons A., Soininen H., Tsolaki M., Kloszewska I., Vellas B., Lovestone S., Mecocci P. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol. Aging 2012, 33:2282-2290.
24. Mangialasche F., Westman E., Kivipelto M., Muehlboeck J.S., Cecchetti R., Baglioni M., Tarducci R., Gobbi G., Floridi P., Soininen H., Kłoszewska I., Tsolaki M., Vellas B., Spenger C., Lovestone S., Wahlund L.O., Simmons A., Mecocci P. AddNeuroMed consortium. Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol. J. Intern. Med. 2013, 273:602-621.
25. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
26. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989, 39:1159-1165.
27. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Wilson R.S., Aggarwal N.T., Scherr P.A. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am. J. Clin. Nutr. 2005, 81:508-514.
28. Mustacich D.J., Bruno R.S., Traber M.G. Vitamin E. Vitam. Horm. 2007, 76:1-21.
29. Nesaretnam K. Multitargeted therapy of cancer by tocotrienols. Cancer Lett. 2008, 269:388-395.
30. Niki E. Tocopherylquinone and tocopherylhydroquinone. Redox Rep. 2007, 12:204-210.
31. Ocke M.C., Schrijver J., Obermann-de Boer G.L., Bloemberg B.P., Haenen G.R., Kromhout D. Stability of blood (pro)vitamins during four years of storage at -20 degrees C: consequences for epidemiologic research. J. Clin. Epidemiol. 1995, 48:1077-1085.
32. Parks E., Traber M.G. Mechanisms of vitamin E regulation: research over the past decade and focus on the future. Antioxid. Redox Signal. 2000, 2:405-412.
33. Patel V., Rink C., Gordillo G.M., Khanna S., Gnyawali U., Roy S., Shneker B., Ganesh K., Phillips G., More J.L., Sarkar A., Kirkpatrick R., Elkhammas E.A., Klatte E., Miller M., Firstenberg M.S., Chiocca E.A., Nesaretnam K., Sen C.K. Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients. J. Nutr. 2012, 142:513-519.
34. Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N., Kokmen E., Waring S.C., Kurland L.T. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995, 273:1274-1278.
35. Polidori M.C., Praticó D., Mangialasche F., Mariani E., Aust O., Anlasik T., Mang N., Pientka L., Stahl W., Sies H., Mecocci P., Nelles G. High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. J. Alzheimers Dis. 2009, 17:921-927.
36. Qiu C., Kivipelto M., von Strauss E. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin. Neurosci. 2009, 11:111-128.
37. Ravaglia G., Forti P., Lucicesare A., Pisacane N., Rietti E., Mangialasche F., Cecchetti R., Patterson C., Mecocci P. Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort. Am. J. Clin. Nutr. 2008, 87:1306-1313.
38. Reiter E., Jiang Q., Christen S. Anti-inflammatory properties of alpha- and gamma-tocopherol. Mol. Aspects Med. 2007, 28:668-691.
39. Ricciarelli R., Argellati F., Pronzato M.A., Domenicotti C. Vitamin E and neurodegenerative diseases. Mol. Aspects Med. 2007, 28:591-606.
40. Rouhiainen P., Rouhiainen H., Salonen J.T. Association between low plasma vitamin E concentration and progression of early cortical lens opacities. Am. J. Epidemiol. 1996, 144:496-500.
41. Sen C.K., Khanna S., Rink C., Roy S. Tocotrienols: the emerging face of natural vitamin E. Vitam. Horm. 2007, 76:203-261.
42. Shukitt-Hale B., Galli R.L., Meterko V., Carey A., Bielinski D.F., McGhie T., Joseph J.A. Dietary supplementation with fruit polyphenolics ameliorates age-related deficits in behavior and neuronal markers of inflammation and oxidative stress. Age (Dordr) 2005, 27:49-57.
43. Smith G.E., Petersen R.C., Parisi J.E., Ivnik R.J., Kokmen E., Tangalos E.G., Waring S.C. Definition, course, and outcome of mild cognitive impairment. Aging Neuropsychol. Cogn. 1996, 3:141-147.
44. Solomon A., Kareholt I., Ngandu T., Winblad B., Nissinen A., Tuomilehto J., Soininen H., Kivipelto M. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology 2007, 68:751-756.
45. Stewart R., White L.R., Xue Q.L., Launer L.J. Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch. Neurol. 2007, 64:103-107.
46. 2-isoprostanes and the risk of Alzheimer's disease and dementia: a prospective population-based study. J. Alzheimers Dis. 2009, 18:71-78.
47. The ATBC Cancer Prevention Study Group The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann. Epidemiol. 1994, 4:1-10.
48. Traber M.G. Mechanisms for the prevention of vitamin E excess. J. Lipid Res 2013, (March 15). 10.1194/jlr.R032946.
49. Traber M.G., Frei B. Micronutrient concentrations and subclinical atherosclerosis in adults with HIV. Am. J. Clin. Nutr. 2010, 92:266-267. (author reply 267).
50. Traber M.G., Jialal I. Measurement of lipid-soluble vitamins-further adjustment needed?. Lancet 2000, 355:2013-2014.
51. Tsukamoto K., Watanabe T., Matsushima T., Kinoshita M., Kato H., Hashimoto Y., Kurokawa K., Teramoto T. Determination by PCR-RFLP of apo E genotype in a Japanese population. J. Lab. Clin. Med. 1993, 121:598-602.
52. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
53. Weinstein S.J., Wright M.E., Pietinen P., King I., Tan C., Taylor P.R., Virtamo J., Albanes D. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J. Natl. Cancer Inst. 2005, 97:396-399.
54. Williamson K.S., Gabbita S.P., Mou S., West M., Pye Q.N., Markesbery W.R., Cooney R.V., Grammas P., Reimann-Philipp U., Floyd R.A., Hensley K. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide 2002, 6:221-227.
55. Williamson K.S., Hensley K., Floyd R.A. HPLC with electrochemical and photodiode array detection analysis of tocopherol oxidation and nitration products in human plasma. Methods in Biological Oxidative Stress 2003, 67-78. Humana Press, Totowa, NJ. K. Hensley, R.A. Floyd (Eds.).
56. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Nordberg A., Backman L., Albert M., Almkvist O., Arai H., Basun H., Blennow K., de Leon M., DeCarli C., Erkinjuntti T., Giacobini E., Graff C., Hardy J., Jack C., Jorm A., Ritchie K., van Duijn C., Visser P., Petersen R.C. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 2004, 256:240-246.
57. Wright M.E., Lawson K.A., Weinstein S.J., Pietinen P., Taylor P.R., Virtamo J., Albanes D. Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-tocopherol, Beta-carotene Cancer Prevention study. Am. J. Clin. Nutr. 2006, 84:1200-1207.